Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1987 2
1988 3
1989 1
1990 2
1991 1
1992 1
1998 1
1999 1
2007 1
2010 1
2012 1
2016 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
Harron DW, Brogden RN. Harron DW, et al. Drugs. 1987 Dec;34(6):617-47. doi: 10.2165/00003495-198734060-00001. Drugs. 1987. PMID: 3322781 Review.
In non-comparative studies propafenone 450 and 900 mg/day orally significantly suppressed premature ventricular complexes and couplets in 96% and 75% of patients, respectively, and abolished ventricular tachycardia in 75% of patients. Efficacy was confirmed i …
In non-comparative studies propafenone 450 and 900 mg/day orally significantly suppressed premature ventricular complexes and coup …
Risk assessment of post-myocardial infarction patients with preserved ejection fraction using 45-min short resting Holter electrocardiographic recordings.
Triantafyllou K, Fragakis N, Gatzoulis KA, Antoniadis A, Giannopoulos G, Arsenos P, Tsiachris D, Antoniou CK, Trachanas K, Tsimos K, Vassilikos V. Triantafyllou K, et al. Ann Noninvasive Electrocardiol. 2023 Nov;28(6):e13087. doi: 10.1111/anec.13087. Epub 2023 Sep 12. Ann Noninvasive Electrocardiol. 2023. PMID: 37700553 Free PMC article.
This study aimed to evaluate the performance of NIRFs extracted from 45-min short resting Holter ECG recordings (SHR), in predicting ventricular tachycardia inducibility with programmed ventricular stimulation (PVS) in post-MI patients with preserved left ventric …
This study aimed to evaluate the performance of NIRFs extracted from 45-min short resting Holter ECG recordings (SHR), in predicting vent …
Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
Moak JP, Smith RT, Garson A Jr. Moak JP, et al. J Am Coll Cardiol. 1987 Oct;10(4):824-9. doi: 10.1016/s0735-1097(87)80276-0. J Am Coll Cardiol. 1987. PMID: 3655149 Free article.
Forty-two children and young adults (age range 5 months to 34 years, mean 15.5 years) were treated with mexiletine. Arrhythmias treated were ventricular tachycardia (25), ventricular couplets (8), multiform ventricular premature beats (4) and frequent …
Forty-two children and young adults (age range 5 months to 34 years, mean 15.5 years) were treated with mexiletine. Arrhythmias treated were …
Oral flecainide for the treatment of drug-resistant ventricular ectopy.
Strasberg B, Stein S, Sclarovsky S. Strasberg B, et al. Isr J Med Sci. 1990 May;26(5):258-61. Isr J Med Sci. 1990. PMID: 1696248
Flecainide acetate was administered at a dose of 100 mg twice daily to 15 patients with drug-resistant ventricular ectopy. Eleven patients had evidence of organic heart disease. ...In only one patient who showed a 69% suppression of ventricular ectopy did …
Flecainide acetate was administered at a dose of 100 mg twice daily to 15 patients with drug-resistant ventricular ectopy. Eleven pat …
The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.
Hayashi M, Denjoy I, Hayashi M, Extramiana F, Maltret A, Roux-Buisson N, Lupoglazoff JM, Klug D, Maury P, Messali A, Guicheney P, Leenhardt A. Hayashi M, et al. Europace. 2012 Sep;14(9):1344-51. doi: 10.1093/europace/eus031. Epub 2012 Mar 1. Europace. 2012. PMID: 22383456
AIMS: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmic disorder with a highly malignant clinical course. ...Exercise-stress test, which was considered positive with the induction of ventricular tachycardia or premature ventr …
AIMS: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmic disorder with a highly malignant clinic …
High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP. Haugaa KH, et al. Europace. 2010 Mar;12(3):417-23. doi: 10.1093/europace/eup448. Epub 2010 Jan 26. Europace. 2010. PMID: 20106799
Mutation carriers underwent an exercise test at inclusion time and 3 months after the initiation of beta-blocker therapy in the highest tolerable dose. The occurrence of ventricular premature beats, couplets, and non-sustained ventricular arrhythmias ( …
Mutation carriers underwent an exercise test at inclusion time and 3 months after the initiation of beta-blocker therapy in the highe …
The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART).
Brooksby P, Batin PD, Nolan J, Lindsay SJ, Andrews R, Mullen M, Baig W, Flapan AD, Prescott RJ, Neilson JM, Cowley AJ, Fox KA. Brooksby P, et al. Eur Heart J. 1999 Sep;20(18):1335-41. doi: 10.1053/euhj.1999.1542. Eur Heart J. 1999. PMID: 10462468
There is some, but not consistent, evidence that QT interval parameters may act as predictors of mortality, in particular sudden death, in patients with heart failure. In an adequately powered prospective study we have studied QT interval parameters in patients with stable …
There is some, but not consistent, evidence that QT interval parameters may act as predictors of mortality, in particular sudden death, in p …
New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias.
Perticone F, Ceravolo R, De Novara G, Torchia L, Cloro C. Perticone F, et al. Magnes Res. 1992 Dec;5(4):265-72. Magnes Res. 1992. PMID: 1296762
Antiarrhythmic magnesium (Mg) therapy was evaluated in 20 normomagnesaemic patients affected by ischaemic dilated cardiomyopathy (ID) and severe ventricular arrhythmias, and in 10 patients with torsade de pointes (TdP) occurring in the setting of acquired QT interva …
Antiarrhythmic magnesium (Mg) therapy was evaluated in 20 normomagnesaemic patients affected by ischaemic dilated cardiomyopathy (ID) …
Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
Kim SG, Mercando AD, Tam S, Fisher JD. Kim SG, et al. J Am Coll Cardiol. 1989 Mar 1;13(3):659-64. doi: 10.1016/0735-1097(89)90608-6. J Am Coll Cardiol. 1989. PMID: 2918173 Free article.
At baseline before therapy, the mean number of ventricular premature complexes per hour, was 608 +/- 757, of couplets per hour was 22.4 +/- 45.8 and of episodes of nonsustained ventricular tachycardia/24 h was 219.7 +/- 758.2. ...Individually, an effec …
At baseline before therapy, the mean number of ventricular premature complexes per hour, was 608 +/- 757, of couplets p …
Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
Dinh H, Baker BJ, de Soyza N, Murphy ML. Dinh H, et al. Am Heart J. 1988 Jan;115(1 Pt 1):92-6. doi: 10.1016/0002-8703(88)90522-4. Am Heart J. 1988. PMID: 3336989
Thirty-two men with chronic ventricular arrhythmias responded to propafenone, a new potent antiarrhythmic agent, in short-term trials with 85% or greater reduction of total ventricular premature complexes (VPCs) per hour, 95% or greater reduction of ventricular …
Thirty-two men with chronic ventricular arrhythmias responded to propafenone, a new potent antiarrhythmic agent, in short-term trials …
19 results